BUZZ-Allergan Inc: In talks with Actavis - Bloomberg

Wed Nov 12, 2014 10:56am EST
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Botox-maker's shares up 1.06 pct at $197.43; Actavis Plc shares down 1.16 pct at $240.79

** Actavis in talks to buy Allergan for at least $60 bln, Bloomberg reports, citing sources

** Deal could culminate this month, Bloomberg reports (

** Allergan, which has a market value of about $58 billion, is currently fending off a hostile takeover from Canadian drugmaker Valeant Pharmaceuticals Inc and activist investor William Ackman's Pershing Square Capital Management

** Up to Tuesday's close, Allergan's shares up about 38 pct since April 21, when Valeant first made its bid

** U.S.-listed shares of Valeant marginally up at $130.21